✦ LIBER ✦

NCIC CTG IND102: a phase II study of the oral platinum compound BMS-182751 in patients with advanced and or recurrent squamous cell carcinoma of the cervix

✍ Scribed by M. Trudeau; G. Stuart; H. Hirte; P. Drouin; M. Plante; P. Bessette; H. Dulude; D. Lebwohl

Book ID: 117667881
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 162 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(99)81342-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Study of Gemcitabine and Cisp

A Phase II Study of Gemcitabine and Cisplatin in Patients with Advanced, Persistent, or Recurrent Squamous Cell Carcinoma of the Cervix

✍ Alexander F. Burnett; Lynda D. Roman; Agustin A. Garcia; Laila I. Muderspach; Ke 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 34 KB

907 ORAL A Phase II study of temsirolimu

907 ORAL A Phase II study of temsirolimus (CCI-779) in patients with metastatic and/or recurrent endometrial cancer — NCIC CTG IND 160

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Cis-platinum in treatment of advanced or

Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase ii study of the gynecologic oncology group

✍ Tate Thigpen; Hugh Shingleton; Howard Homesley; Leo Lagasse; John Blessing 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 3 views

A Phase II Study of Carboplatin and Cisp

A Phase II Study of Carboplatin and Cisplatin in Advanced or Recurrent Squamous Carcinoma of the Uterine Cervix

✍ Mitchell Morris; David M. Gershenson; Thomas W. Burke; Michele Follen Mitchell; 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 263 KB

408 A phase II study of erlotinib in com

408 A phase II study of erlotinib in combination with cisplatin in patients with recurrent or metastatic squamous cell cancer of the head and neck (PHL-002e/NCIC CTG IND.157)

✍ E. Winquist; D. Soulieres; E. Chen; M. Tsao; M. Klein; G. Pond; J. Dancey; E. Ei 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Phase II study of carboplatin and liposo

Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix

✍ Claire F. Verschraegen; John J. Kavanagh; Evelyne Loyer; Diane Bodurka-Bevers; A 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## BACKGROUND. The activity of the combination of carboplatin and liposomal doxorubicin was tested in a Phase II study of patients with recurrent cervical carcinoma. ## METHODS. The combination of carboplatin (area under the concentration curve [AUC], 5) and liposomal doxorubicin (Doxil; starti